Interviews - Ambu (CPH:AMBU-B) President and CEO Lars Marcher discusses Ambu’s global sales position and growth strategy in an exclusive interview with PropThink.com. According to Marcher, Ambu … Continue Reading
Read NowInterviews - Zealand Pharma (ZEAL.CO) President and CEO Dr. David Solomon details timeframes in the development of lixisenatide, a treatment for type-2 diabetes licensed to Sanofi (SNY), … Continue Reading
Read NowInterviews - Photocure (PHO.OL) President and CEO Kjetil Hestdal discusses the company’s photodynamic technology harnessed in Hexvix and Allumera. Hexvix, branded as Cysview in the U.S., aids … Continue Reading
Read NowInterviews - In an exclusive video interview with PropThink.com, Sagent Pharmaceuticals (SGNT) President and CEO, Jeff Yordon, comments on healthcare reform, addressing pricing controls introduced with the … Continue Reading
Read NowInterviews - Exact Sciences’ (NASDAQ: EXAS) Chief Executive, Kevin Conroy, speaks with PropThink.com during a Global Healthcare Conference in New York City in June. With data from … Continue Reading
Read Now